The global specialty animal feed additives and nutrition market is on track to reach $60.59 billion by 2035, growing at a 4.58% to 6.1% CAGR.
Year-to-date (YTD) 2026 highlights a shift toward gut integrity diagnostics, precise nutrient encapsulation, biosecurity, and regulatory-compliant biotics as direct alternatives to antimicrobial growth promoters (AGPs).
Below is global analysis incorporating Kemin, Alltech, Orffa, Evonik, Novonesis, and key European market moves.
1. Enterprise Portfolio Realignments & Market Structuring
The global feed additive landscape in 2026 is defined by consolidation and structural divestments to optimize balance sheets for specialized R&D:
The global animal feed supplements and specialty additives market is valued at $59.7 billion. 2026 YTD has seen significant activity across gut-health biotics, enzyme platforms, and climate-focused methane-reduction supplements.
Major market dynamics include strategic portfolio realignments—most notably dsm-firmenich’s €2.2 billion sale of its core Animal Nutrition & Health (ANH) business to private equity firm CVC, following the €1.5 billion transaction transferring its feed enzymes business to Novonesis.

-
dsm-firmenich (ANH Divestment): Executed a €2.2 billion transaction transferring its standalone Animal Nutrition & Health (ANH) division to private equity firm CVC, maintaining a 20% stake.
-
Alltech / Akralos Debut: Alltech launched Akralos Animal Nutrition, a North American joint venture aimed at streamlining supply chain scale and compound feed delivery across livestock sectors.
-
Novonesis Group: Formally unified legacy Novozymes and Chr. Hansen bio-solutions platforms alongside the acquired dsm-firmenich feed enzymes business.
2. Comprehensive 2026 YTD Product Launches by Leading Players

Kemin Industries
Focusing heavily on precision encapsulation to protect active ingredients from early degradation in the rumen:
-
MetiPEARL®, LysiGEM®, & CholiGEM® Updates: Deployed spray-freezing and GEM fluid-bed matrix technologies to deliver rumen-protected amino acids (Methionine, Lysine) and Choline directly to the small intestine.
-
Nutritional Purpose: Eliminates premature nutrient degradation, allowing precise dose-response formulation for high-yield dairy herds.
Alltech
Expanding beyond core nutrition into circular biomass and environmental feed solutions:
-
REVELEX™ Platform: Launched in mid-2026, targeting anaerobic digestion optimization and feed-to-energy conversion systems for large-scale livestock and biogas producers.
-
Alltech Agri-Food Outlook (2026): Reported 2025 global feed production reached 1.44 billion metric tons (+2.9% YoY), driven by structural efficiency rather than herd expansion alone.
Orffa Additives International (Netherlands)
Pioneering the synthesis of physical feed additives with real-time farm diagnostics:
-
Florates™ & Orffa Science Lab (Breda): Opened a dedicated science lab in Breda and introduced Florates, a non-invasive cloacal sampling diagnostic tool using qPCR to generate real-time metrics across three functional indices: Productivity, Gut Integrity, and Microbial Balance.
-
Commercial Purpose: Connects diagnostic data directly to targeted in-feed additive dosing, reducing unnecessary prophylactic treatment.
Evonik Animal Nutrition (Germany)
-
Ecobiol® PRO: Launched an advanced probiotic feed additive engineered specifically to replace antibiotic growth promoters in poultry production.
-
Amino Acid Portfolio Expansion: Extended bio-optimized essential amino acids (DL-Methionine, Biolys® L-Lysine) across European markets to handle raw-grain price swings.
Adisseo (France / Bluestar)
-
R&D Application Expansion: Expanded European technical application capabilities in early 2026, scaling next-generation liquid methionine (Rhodimet®) and gut-health enzymes.
Novonesis
-
Solvens™: Launched a targeted piglet probiotic designed to strengthen post-weaning gut wall integrity, reducing dependency on zinc oxide and post-weaning antibiotics.
3. Financial Performance Comparison (H1 2026 / YTD)
Company / Entity |
H1 2026 Revenue (Segment / Group) |
Organic Growth (YoY) |
Primary Growth Drivers |
Novonesis |
€2,235.5 Million |
+8.0% |
Solvens deployment, volume growth in poultry and swine enzymes |
dsm-firmenich |
€4,664.0 Million |
+5.0% (LFL) |
Portfolio realignments ahead of the €2.2B ANH sale to CVC |
Evonik (Advanced Tech) |
€1,647.0 Million (Q2) |
+9.0% |
Higher essential amino acid pricing and expanded probiotic sales |
Alltech (Global Footprint) |
Private Enterprise |
Estimated +3.0–4.0% |
Steady growth across compound feed sectors (1.44B MT global footprint) |
Orffa (Specialty Portfolio) |
Private European Entity |
Estimated +5.5–6.5% |
Expansion of diagnostic-led additive solutions (Florates) |
4. Segment & Market Share Breakdown
Dynamic shifts in functional feed additives highlight market distribution trends:

Core Drivers Shaping H2 2026 Formulations
-
Diagnostic-Coupled Nutrition: Moving from static feed formulations to real-time microflora diagnostic tools (e.g., Orffa Florates) to dynamically adjust probiotic dosages on farm.
-
Encapsulation & Rumen Bypass Tech: High adoption of precise-release matrix coatings (Kemin MetiPEARL/LysiGEM) to ensure amino acids pass through the rumen un-degraded.
-
AGP Alternatives Under EU 2026 Regulations: Strict implementation of European Veterinary Medicines Regulation (EU 2026/171 and 2026/164 directives) driving high adoption of targeted probiotics (Evonik Ecobiol PRO, Novonesis Solvens).

